Ann: Green Whistle gets the Green Light - FDA Clears US Trial, page-58

Listening back over he webinar, to me, the cap raise didn't sound confirmed, but was depending on whether future sales from Europe would cover the costs.

From the webinar regarding capital raise:
Gordon:
"I think at some point, we will probably do some sort of further capital raise. But, as part of the answer there, but I, but to just put a bit of further context to that, first of all, we are in a pretty strong position at the moment, Um and that's a good place to start from, but also this um situation where we are seeing, such strong sales growth, come out of Europe, and elsewhere, is actually, it's all going in the right direction, so it'll place context around, the timing of any potential capital raise.

All in my opinion.